| Literature DB >> 31875645 |
Qiaowei Li1, Fan Lin1, Zhonghai Gao2, Feng Huang1, Pengli Zhu1.
Abstract
BACKGROUND As epidemiological findings are still controversial, animal experiments have probed into the potential link between uric acid and damage to microvessels. The present study examined the association of serum uric acid (SUA) with the retinal vascular caliber and retinal vascular fractal dimension (Df) in males and females utilizing a cross-sectional study design. MATERIAL AND METHODS A total of 2169 subjects from 7 sampling units were enrolled. Retinal vascular parameters were analyzed with a semi-automated computer-based program. The central retinal arteriolar equivalent, central retinal venular equivalent, and Df were linearly and categorically measured in males and females and at various SUA levels. RESULTS The analysis revealed that per SD SUA increase was associated with an increase of 0.848 µm in the arteriolar caliber, and an increase of 1.618 µm in the venular caliber only in females. No significant correlation was found between Df and SUA in females or in males. Further adjusted for more cardiovascular risk factors did not change the results. CONCLUSIONS By exploring a Chinese coastal population, we elucidate the association between SUA with retinal arterioles and venules in females. Df, as a mathematical index of retinal blood vascular complexity, is not correlated with SUA or hyperuricemia.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31875645 PMCID: PMC6944035 DOI: 10.12659/MSM.919972
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Figure 1Flowchart of the study population.
hyperuricemia
and age, systolic blood pressure, pulse pressure, heart rate, hs-CRP, UACR, HbA1c, baPWV, sex, smoking, drinking, less than 1 year of primary education, hypertension, or diabetes mellitus.Characteristics of participants with and without hyperuricemia.
| Variables | All participants | Participants without hyperuricemia | Participants with hyperuricemia | Age- and sex-adjusted differences | |
|---|---|---|---|---|---|
| N | 2169 | 1779 | 390 | ||
| CRAE (μm) | 134.10 (11.13) | 133.84 (11.09) | 135.27 (11.28) | 0.022 | −1.47 (−2.68, −2.54) |
| CRVE (μm) | 184.03 (16.62) | 183.65 (16.45) | 185.78 (17.32) | 0.022 | −2.26 (−4.53, −4.07) |
| Df | 1.37 (0.05) | 1.37 (0.05) | 1.36 (0.05) | 0.845 | −0.01 (−0.06, 0.04) |
| Age (years) | 52.90 (11.95) | 51.74 (11.92) | 52.64 (12.10) | 0.178 | −0.90 (−2.21, 0.40) |
| MABP (mmHg) | 94.67 (14.10) | 94.42 (14.06) | 95.80 (14.21) | 0.081 | −0.98 (−2.39, 0.44) |
| Systolic blood pressure (mmHg) | 126.94 (21.94) | 126.68 (22.04) | 128.11 (21.46) | 0.243 | −0.65 (−2.74, 1.44) |
| Diastolic blood pressure (mmHg) | 78.55 (11.85) | 78.32 (11.74) | 79.62 (12.32) | 0.050 | −1.09 (−2.35, 0.16) |
| Pulse pressure (mmHg) | 48.39 (15.88) | 48.36 (15.98) | 48.49 (15.42) | 0.881 | 0.45 (−1.07, 1.96) |
| Heart rate (bpm) | 71.22 (9.28) | 71.26 (9.35) | 71.04 (8.92) | 0.677 | 0.19 (−8.22, 1.21) |
| Waist-to-hip ratio | 0.85 (0.07) | 0.85 (0.07) | 0.87 (0.07) | <0.001 | −0.02 (−0.03, −0.01) |
| Body mass index (kg/m2) | 23.83 (3.42) | 23.71 (3.37) | 24.36 (3.58) | 0.001 | −0.62 (−0.99, −0.25) |
| Triglyceride (mmol/L) | 0.86 (0.50) | 0.82 (0.45) | 1.01 (0.68) | <0.001 | −0.19 (−0.24, −0.13) |
| Total cholesterol (mmol/L) | 5.03 (1.05) | 4.96 (1.01) | 5.31 (1.17) | <0.001 | −0.34 (−0.45, −0.22) |
| HDL-C (mmol/L) | 1.23 (0.33) | 1.24 (0.33) | 1.14 (0.31) | <0.001 | 0.11 (0.01, 0.14) |
| LDL-C (mmol/L) | 2.79 (0.88) | 2.72 (0.87) | 3.07 (0.91) | <0.001 | −0.33 (−0.43, −0.24) |
| Fasting glucose (mmol/L) | 5.31 (1.50) | 5.25 (1.27) | 5.57 (2.26) | <0.001 | −0.32 (−0.48, −0.15) |
| eGFR (ml/min*1.73 m2) | 103.20 (33.66) | 105.35 (34.31) | 93.36 (28.53) | <0.001 | 11.78 (8.28,15.28) |
| hs-CRP (mg/L) | 1.38 (3.38) | 1.34 (3.47) | 1.56 (2.89) | 0.240 | −0.18 (−0.55, 0.18) |
| UACR (mg/mmol) | 2.48 (4.51) | 2.41 (4.09) | 2.78 (6.06) | 0.149 | −0.32 (−0.81, 0.17) |
| HbA1c( %) | 5.72 (0.68) | 5.71 (0.70) | 5.75 (0.58) | 0.289 | −0.03 (−0.10, 0.05) |
| baPWV (cm/s) | 1417.72 (338.07) | 1412.41 (339.90) | 1441.92 (328.92) | 0.118 | −14.06 (−43.25, 15.14) |
| Serum uric acid (μmol/L) | 315.04 (84.82) | 286.93 (59.30) | 443.28 (62.63) | <0.001 | −156.18 (−162.16, −150.20) |
| Sex (% Male) | 812 (37.4%) | 666 (37.44%) | 146 (37.44%) | 1.000 | 0.3 (−4.9, 5.6) |
| Smoking | 415 (19.13%) | 349 (19.62%) | 66 (16.92%) | 0.220 | 2.8 (−0.7, 6.2) |
| Smoking and passive smoking | 1144 (52.74%) | 954 (53.63%) | 190 (48.72%) | 0.079 | 4.7 (−0.7, 10.1) |
| Drinking | 341 (15.72%) | 278 (15.63%) | 63 (16.15%) | 0.796 | −0.5 (−3.9, 2.9) |
| Less than 1 year primary education | 835 (38.50%) | 675 (37.94%) | 160 (41.01%) | 0.257 | −1.7 (−6.5, 3.1) |
| Diabetes | 272 (12.54%) | 214 (12.20%) | 58 (14.87%) | 0.125 | −2.4 (−6.0, 1.2) |
| Hypertension | 819 (37.76%) | 655 (36.82%) | 164 (42.05%) | 0.117 | −3.7 (−8.4, 1.1) |
p values refer to difference between hyperuricemia individuals and normal subjects.
Hyperuricemia was defined as serum uric acid level ≥420 μmol/L in men or ≥360 μmol/L in women. CRAE – central retinal arteriolar equivalent; CRVE – central retinal venular equivalent; Df – fractal dimension; MABP – mean arterial blood pressure; HDL-C – high-density lipoprotein cholesterol; LDL-C – low-density lipoprotein cholesterol; eGFR – estimated glomerular filtration rate; hs-CRP – hypersensitive C-reactive protein; UACR – urinary albumin-creatinine ratio; baPWV – brachial-ankle pulse wave velocity.
Association between uric acid and changes in CRAE, CRVE, and 100 Df for males.
| Linear regression model | Continuous uric acid | Quartiles of uric acid, median (interquartile range), μmol/L | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 248 (124–285) | 316 (286–343) | 370 (344–399) | 451 (400–688) | ||||||
| Age-change in CRAE (SE) | 0.350 (0.350) | 0.359 | Referent | 1.090 (1.109) | 0.326 | 0.763 (1.112) | 0.493 | 1.139 (1.111) | 0.305 |
| Multivariable change in CRAE (SE) | −0.005 (0.438) | 0.991 | Referent | 0.752 (1.165) | 0.519 | −0.001 (1.218) | 1.000 | 0.387 (1.315) | 0.769 |
| Age-change in CRVE (SE) | 0.175 (0.613) | 0.815 | Referent | −0.480 (1.726) | 0.781 | −0.759 (1.731) | 0.661 | 0.728 (1.728) | 0.674 |
| Multivariable change in CRVE (SE) | 0.788 (0.701) | 0.295 | Referent | 0.914 (1.820) | 0.616 | 1.235 (1.903) | 0.517 | 2.978 (2.054) | 0.148 |
| Age-change in 100Df (SE) | −0.175 (0.175) | 0.254 | Referent | −0.238 (0.465) | 0.610 | −0.391 (0.467) | 0.403 | −0.532 (0.466) | 0.254 |
| Multivariable change in 100Df (SE) | −0.114 (0.193) | 0.569 | Referent | −0.064 (0.484) | 0.895 | −0.322 (0.506) | 0.525 | −0.279 (0.547) | 0.610 |
per each SD increase, SD=87.58 μmol/L.
Multivariable models were adjusted for age, smoking and passive smoking, mean arterial blood pressure, waist-to-hip ratio, triglyceride, total cholesterol, LDL-C, HDL-C, eGFR, and HbA1c. CRAE – central retinal arteriolar equivalent; CRVE – central retinal venular equivalent; Df – fractal dimension; LDL-C – low-density lipoprotein cholesterol; HDL-C – high-density lipoprotein; eGFR – The Estimated Glomerular filtration rate.
Association between uric acid and changes in CRAE, CRVE, and 100Df for females.
| Linear regression model | Continuous uric acid | Quartiles of uric acid, median (interquartile range), μmol/L | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 217 (111–242) | 264 (243–285) | 307 (286–335) | 385 (340–674) | ||||||
| Age-change in CRAE (SE) | 0.848 (0.308) | 0.004 | Referent | −0.758 (0.845) | 0.370 | 0.564 (0.846) | 0.505 | 1.311 (0.847) | 0.122 |
| Multivariable change in CRAE (SE) | 1.002 (0.308) | 0.002 | Referent | −0.497 (0.833) | 0.550 | 1.075 (0.843) | 0.202 | 1.833 (0.857) | 0.033 |
| Age-change in CRVE (SE) | 1.618 (0.462) | 0.001 | Referent | −0.024 (1.221) | 0.984 | 2.627 (1.223) | 0.032 | 4.140 (1.223) | 0.001 |
| Multivariable change in CRVE (SE) | 1.387 (0.462) | 0.002 | Referent | −0.036 (1.214) | 0.976 | 2.696 (1.228) | 0.028 | 3.834 (1.250) | 0.002 |
| Age-change in 100Df (SE) | 0.077 (0.154) | 0.713 | Referent | −0.585 (0.372) | 0.117 | −0.354 (0.373) | 0.343 | −0.092 (0.373) | 0.806 |
| Multivariable change in 100Df (SE) | 0.108 (0.139) | 0.454 | Referent | −0.508 (0.370) | 0.170 | −0.225 (0.377) | 0.551 | 0.065 (0.393) | 0.869 |
per each SD increase, SD=77.06 μmol/L.
Multivariable models were adjusted for age, smoking and passive smoking, mean arterial blood pressure, waist-to-hip ratio, triglyceride, total cholesterol, LDL-C, HDL-C, eGFR, and HbA1c. CRAE – central retinal arteriolar equivalent; CRVE – central retinal venular equivalent; Df – fractal dimension; LDL-C – low-density lipoprotein cholesterol; HDL-C – high-density lipoprotein; eGFR – estimated glomerular filtration rate.